• Home

  • About Us

  • Development

  • Partnerships

  • Contact

  • More

    Use tab to navigate through the menu items.

    AAD and the Dermatology Entrepreneurship Conference in San Francisco

    We'll be at the Dermatology Entrepreneurship Conference on March 19 and at the American Academy of Dermatology's Annual Meeting from March 20 - 23. Both shows are in San Francisco. Please let us know if you would like to meet. #aad #dermatology #entrepreneurs #raredisease #orphandrugs #pharmaceuticals #sanfrancisco #healthcare #ichthyosis #biotech

    Meet us at DCAT

    Patagonia Pharmaceuticals will be in NYC from March 16 - 17 for DCAT . Please let us know if you'd like to schedule a meeting. #dcat #pharmaceuticals #orphandrugs #dermatology #skin #ichthyosis #nyc #patagonia #rarediseases #newyork

    Biotech Primer's Drug Development Immersion

    Patagonia will attend Biotech Primer's Drug Development Immersion course in West Windsor, NJ from February 11-12. Please reach out to us if you would like to connect. #drugdevelopment #biotech #fda #orphandrugs #patagonia

    One Month Until Rare Disease Day

    Rare Disease Day is just one month away. EURODIS first launched the campaign in 2008, and it has quickly grown into a global movement. The main objective is to “raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients' lives.” On February 28, there will be various activities and events around the world dedicated to supporting rare communities. Please visit www.rarediseaseday.org/events/world to see what is going on in

    Subscribe for updates

    Recent Posts

    Patagonia Awarded $1.5MM Grant from the FDA

    Thank you FIRST!

    FDA Commissioner Gottlieb Outlines Efforts to Advance Biotechnology Innovation

    We're headed to Nashville!

    Recent Budget Approval Increases Funding Across Nearly All US Science Agencies

    Today is Rare Disease Day 2018!

    Today is Rare Disease Day 2018!

    Patagonia Completes Phase 2a Clinical Study for PAT-001

    Patagonia Completes Enrollment in Phase IIa Study

    Developing Drugs for Rare Diseases: Insights for Pharma Execs

    FDA is Advancing the Goals of the Orphan Drug Act

    Patagonia Pharmaceuticals, LLC

    50 Tice Blvd, Suite A26

    Woodcliff Lake, NJ 07677

    For more info: info@patagoniarx.com

    © 2021 by Patagonia Pharmaceuticals, LLC